CYTIP

CYTIP (Cybr) is an intracellular scaffold protein that negatively regulates leukocyte integrin activation and adhesion, thereby controlling immune cell trafficking and dendritic cell (DC)–T-cell interactions (PMID:12606567, PMID:16809763). It binds cytohesin-1 through reciprocal coiled-coil domains and enhances cytohesin-1-mediated nucleotide exchange on ARF GTPases in vitro (PMID:11867758). Upon integrin signaling or phorbol-ester stimulation, CYTIP is recruited to the cell cortex via its PDZ domain and sequesters cytohesin-1 away from the plasma membrane, repressing LFA-1/β2-integrin-mediated adhesion to ICAM-1 (PMID:12606567). In DCs, CYTIP is induced during maturation, accumulates at DC–T-cell contact zones, and mediates deattachment to permit dissolution of the immune synapse (PMID:16204317). In vivo, CYTIP-deficient mice show reduced circulating leukocytes and impaired lymphocyte trafficking under proinflammatory conditions, alongside an enhanced DC immunostimulatory capacity, identifying CYTIP as a suppressor of DC activation (PMID:16809763, PMID:22488362). Both HSV-1 and HCMV exploit proteasome-dependent degradation of CYTIP as an immune-evasion strategy, activating β2-integrins to lock infected DCs in a high-adhesion, migration-impaired state (PMID:21562043, PMID:28484459).

1. 2002 Medium

   Establishing CYTIP's primary molecular partner and biochemical effect addressed how this protein engages the integrin-regulatory machinery; it was shown to bind cytohesin-1 and potentiate its ARF GEF activity.

   Evidence Co-immunoprecipitation of overexpressed proteins in 293T cells and in vitro ARF GEF (GTPγS binding) assay

   PMID:11867758

   Open questions at the time

   • Interaction shown only with overexpressed proteins, not endogenous
   • Functional consequence of GEF enhancement on adhesion not yet tested
   • No cellular localization context
2. 2003 High

   Resolving how CYTIP affects integrin function revealed it acts as a sequestration protein, using its PDZ domain to pull cytohesin-1 off the membrane and repress LFA-1-mediated adhesion.

   Evidence Fluorescence localization, PDZ-domain interaction studies, and Jurkat–ICAM-1 adhesion assay with co-expression requirement

   PMID:12606567

   Open questions at the time

   • Relies on overexpression in Jurkat cells
   • Cortical recruitment trigger and adaptor partners not fully mapped
   • In vivo relevance not addressed
3. 2005 High

   Linking CYTIP to DC biology defined its physiological setting; it is maturation-induced, localizes to DC–T-cell contacts, and mediates synapse deattachment to tune T-cell priming.

   Evidence siRNA knockdown in human DCs with DC–T-cell and fibronectin adhesion assays, T-cell priming assays, and contact-zone microscopy

   PMID:16204317

   Open questions at the time

   • siRNA-based loss of function only
   • Molecular link between deattachment and reduced priming not fully resolved
   • Does not establish requirement in vivo
4. 2006 High

   Genetic knockout tested CYTIP's in vivo requirement, showing it regulates leukocyte trafficking and CTL migration under proinflammatory conditions, while also revealing its steady-state role is limited and redundant.

   Evidence Cybr knockout mice analyzed by flow cytometry, peritonitis and tumor challenge models, adoptive DC transfer, and competitive bone marrow reconstitution

   PMID:16809763 PMID:16914744

   Open questions at the time

   • Discrepancy between knockout and overexpression/siRNA phenotypes indicates context-dependence not fully explained
   • Mechanism of trafficking defect at molecular level not dissected in vivo
   • Hematopoietic competitive disadvantage mechanism unknown
5. 2012 High

   A contact hypersensitivity model clarified CYTIP's net immunological output, establishing it as a suppressor of DC immunostimulatory capacity rather than a positive effector.

   Evidence Cytip knockout mice in TNCB-induced CHS model with ear-swelling, IL-12 ELISA, and antigen-specific T-cell proliferation assays

   PMID:22488362

   Open questions at the time

   • Molecular basis for elevated IL-12 production not defined
   • Skin DC migration unaffected, leaving the trafficking role context-specific
   • Link to integrin/cytohesin axis in this phenotype not directly tested
6. 2017 High

   Demonstrating viral targeting of CYTIP showed that pathogens weaponize its degradation; HSV-1 and HCMV trigger proteasomal destruction of CYTIP to activate β2-integrins and immobilize infected DCs.

   Evidence HSV-1 and HCMV infection of human monocyte-derived DCs with Western blot, proteasome inhibitor rescue, integrin activation, adhesion, and transwell migration assays

   PMID:21562043 PMID:28484459

   Open questions at the time

   • Viral factor and E3 ligase mediating CYTIP degradation not identified
   • Whether CXCR4-directed re-routing of HCMV-infected DCs occurs in vivo not established
   • HCMV finding from single lab extending the HSV-1 model

• The identity of the viral and host machinery that targets CYTIP for proteasomal degradation, and how CYTIP's sequestration mechanism integrates with the divergent in vivo phenotypes, remains unresolved.
• No E3 ubiquitin ligase or viral effector identified for CYTIP degradation
• Structural basis of PDZ-mediated cortical recruitment unknown
• Reconciliation of suppressor vs. trafficking-promoting roles incomplete